This is an intriguing finding, as BTN3A1 is required for the phosphoantigen (pAg)-induced activation of Vγ9Vδ2+ T cells in peripheral blood, a subset of γδ T cells not previously implicated in CeD. The gene discussed is BTN3A1; the disease is cranioectodermal dysplasia.